Cargando…
Ketamine and rapid-acting antidepressants: a new era in the battle against depression and suicide
Therapeutic medications for the treatment of depression have serious limitations, particularly delayed onset and low rates of efficacy. However, the discovery that a single subanesthetic dose of ketamine, a glutamate NMDA receptor channel blocker, can produce a rapid (within hours) antidepressant re...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
F1000 Research Limited
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5968361/ https://www.ncbi.nlm.nih.gov/pubmed/29899972 http://dx.doi.org/10.12688/f1000research.14344.1 |